ribavirin has been researched along with Hemochromatosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azim, J; McCurdy, H; Moseley, RH | 1 |
| De Lalla, F; Fabris, P; Giordani, MT; Tositti, G | 1 |
| Maier, KP | 1 |
| Alessio, A; Buonsante, ME; Frider, B; Pellerano, G; Tiscornia, J | 1 |
1 review(s) available for ribavirin and Hemochromatosis
| Article | Year |
|---|---|
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors | 2005 |
3 other study(ies) available for ribavirin and Hemochromatosis
| Article | Year |
|---|---|
Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.
Topics: Anemia, Hemolytic; Antiviral Agents; Drug Therapy, Combination; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Iron Overload; Male; Membrane Proteins; Middle Aged; Mutation; Phlebotomy; Polyethylene Glycols; Porphyria Cutanea Tarda; Recombinant Proteins; Ribavirin | 2008 |
Successfull response to alpha 2b interferon plus ribavirin associated with venesectomies in a patient with chronic hepatitis C and genetic hemochromatosis.
Topics: Antiviral Agents; Hemochromatosis; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Phlebotomy; Recombinant Proteins; Ribavirin | 2003 |
[Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin].
Topics: Antiviral Agents; Hemochromatosis; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Porphyria Cutanea Tarda; Recombinant Proteins; Ribavirin | 2006 |